V CompBrief BY VELARION

Interim Principal Financial Officer and Principal Accounting Officer · IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Matthew Rosinack

FY2025 is the first fiscal year CompBrief holds for Matthew Rosinack as a named executive officer of IOVANCE BIOTHERAPEUTICS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$782,491

6th of 7 named executive officers at Iovance Biotherapeutics by FY2025 total.

7 named officers on file for IOVANCE BIOTHERAPEUTICS, FY2025

See an example →

What this number hides

The filing gives the total. IOVANCE BIOTHERAPEUTICS’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how IOVANCE BIOTHERAPEUTICS’s whole pay program stands against its peers

  • IOVANCE BIOTHERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IOVA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2026 (DEF 14A).

Free

Get Matthew Rosinack’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Matthew Rosinack and every company like it: Velarion Intel, free for 3 days, no card →

Matthew Rosinack compensation by year

IOVANCE BIOTHERAPEUTICS Summary Compensation Table · the one fiscal year held
In US dollars, as IOVANCE BIOTHERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$433,511
Bonus$18,750
Stock awards$239,193
Option awards$0
Non-equity incentive$91,037
Pension and deferred compensation$0
All other$0
Total$782,491

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IOVANCE BIOTHERAPEUTICS, INC. DEF 14A filed April 28, 2026, accession 0001104659-26-050458, and prior-year filings. Open the filing on EDGAR.

How this page was built: the IOVANCE BIOTHERAPEUTICS, INC. filed document, accession 0001104659-26-050458. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU59,060$161,234—
RSU27,348$74,660—
RSU3,907$10,666—

Per the Outstanding Equity Awards at Fiscal Year-End table in IOVANCE BIOTHERAPEUTICS, INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

IOVANCE BIOTHERAPEUTICS’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Daniel KirbyChief Commercial Officer$2,160,595
Frederick VogtInterim Chief Executive Officer and President, General Counsel$1,888,175
Corleen RocheChief Financial Officer$1,455,979
Raj PuriChief Regulatory Officer$1,341,778
Igor BilinskyChief Operating Officer$1,118,062
Matthew Rosinack · this pageInterim Principal Financial Officer and Principal Accounting Officer$782,491
Jean-Marc BelleminFormer Chief Financial Officer$663,104

Matthew Rosinack's compensation dossier, IOVANCE BIOTHERAPEUTICS

You have read Matthew Rosinack's totals and holdings. The dossier adds each equity grant IOVANCE BIOTHERAPEUTICS disclosed for Matthew Rosinack and IOVANCE BIOTHERAPEUTICS's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full IOVANCE BIOTHERAPEUTICS compensation record

free company brief
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within IOVANCE BIOTHERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the IOVANCE BIOTHERAPEUTICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order IOVANCE BIOTHERAPEUTICS's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosuresFull report & benchmarkingExecutive Compensation Report · $500
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are IOVANCE BIOTHERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order IOVA

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Matthew Rosinack's compensation dossier